## Diagnosis: Meningioma ### Clinical Presentation **Key Point:** Progressive focal neurological deficits (motor weakness, speech difficulty) with headaches in a middle-aged patient suggest a mass lesion. The chronicity (2 months) is consistent with a slow-growing tumor like meningioma. ### Imaging Characteristics — Meningioma | Feature | Meningioma | High-Grade Glioma | Brain Metastasis | |---------|-----------|-------------------|------------------| | **Location** | Dural-based (extra-axial) | Intra-axial | Intra-axial (gray-white junction) | | **T1 signal** | Iso-to-hyperintense | Iso-to-hypointense | Iso-to-hypointense | | **T2 signal** | Iso-to-hyperintense | Hyperintense | Hyperintense | | **Enhancement** | Homogeneous (often) | Heterogeneous | Heterogeneous | | **Dural tail** | Present (85%) | Absent | Absent | | **Perilesional edema** | Mild-to-moderate | Severe | Moderate-to-severe | | **Calcification** | Common (20–60%) | Rare | Rare | **High-Yield:** The **dural tail sign** is the most specific imaging finding for meningioma. It represents tumor extension along the dura and is seen in ~85% of meningiomas but is rare in other tumors. ### MRI Hallmarks of Meningioma 1. **Dural tail sign** — thickening and enhancement of dura adjacent to the mass 2. **Iso-to-hyperintense** on both T1 and T2 (due to high cellularity and fibrosis) 3. **Homogeneous enhancement** (though can be heterogeneous in larger tumors) 4. **Extra-axial location** — broad dural base, mass effect on brain parenchyma 5. **Perilesional edema** — present but typically less severe than in high-grade gliomas 6. **Calcification** — common (20–60%) **Clinical Pearl:** Meningiomas are the most common **extra-axial** intracranial tumor in adults. They arise from the dura mater (arachnoid cap cells) and typically present with progressive focal neurological deficits due to mass effect and edema. ### Differential Reasoning ```mermaid flowchart TD A[Brain mass with dural tail]:::outcome --> B{Dural tail present?}:::decision B -->|Yes| C[Meningioma most likely]:::outcome B -->|No| D[Consider other diagnoses]:::action A --> E{Intra-axial or extra-axial?}:::decision E -->|Extra-axial| F[Meningioma, schwannoma, neurofibroma]:::outcome E -->|Intra-axial| G[Glioma, metastasis, lymphoma]:::outcome F --> H[Dural tail sign?]:::decision H -->|Yes| I[Meningioma]:::action H -->|No| J[Schwannoma/neurofibroma]:::action ``` **Why meningioma over alternatives:** - **Dural tail sign** is the key discriminator — highly specific for meningioma (85% sensitivity, >90% specificity) - **Iso-to-hyperintense on T1/T2** is typical for meningioma due to high cellularity; high-grade gliomas are typically hypointense on T1 - **Homogeneous enhancement** is more common in meningioma; metastases and high-grade gliomas tend to be more heterogeneous - **Extra-axial location** (implied by dural tail) excludes intra-axial lesions like glioma and metastasis **Mnemonic:** **DURAL TAIL** = Meningioma (Dura-based, Attachment, Rare in other tumors, Arachnoid origin, Lobe-compressing, Tail sign) 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.